Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone vs Cetrorelix in High Ovarian Response ICSI Cycles
NCT05951400Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Jan 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dydrogesterone in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Beni Suef University. Primary endpoint: Number of Oocytes Retrieved at 1 month. Started Jan 2024; status: completed.
02
Drugs
dydrogesterone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05951400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05951400.